Researchers at the
The nanoemulsions carry antibodies and protein and can generate an immune response against infectious diseases such as influenza, HIV and malaria.
A paper on the development has been published in the international journal SMALL
He said it addressed challenges with existing targeted therapies, such as limited drug-carrying capacity and difficulty of manufacture.
An ability to target specific cells gives the emulsion the potential to overcome side-effects of broad-spectrum treatments such as chemotherapy, which attacks healthy cells as well as cancerous ones.
Dr Sainsbury said the nanoemulsion could hold antibodies, releasing them only when targeted cells were found.
"This is about efficient targeting," he said.
"Nanoemulsions have a long, safe history in pharmaceutical formulations.
The research is a collaboration between Professor
CC AutoTriage1pm-140125-30TagarumaMar-4613958 30TagarumaMar
Most Popular Stories
- Obama Administration Releases Proposal to Regulate For-Profit Colleges
- Apple, HP, Intel May Take a Hit from Slowdown in Smartphone Sales Growth
- Elizabeth Vargas' Husband Marc Cohn Addresses Rumors
- FDIC Files Lawsuit on Behalf of Banks Allegedly Hurt by Libor Scandal
- Keurig Adds Peet's coffee, Alters Starbucks deal
- Motley Crue's Nikki Sixx Marries Model Courtney Bingham
- U.S. to Relinquish Gov't Control Over Internet
- Chinese e-Commerce Giant Alibaba Gears for IPO in U.S.
- Some California Cities Seeking Water Independence
- Will Missing Malaysian Jet Prompt Aviation System Change?